BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28203453)

  • 1. Association of Osteoprotegerin with Obesity, Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Children.
    Erol M; Bostan Gayret O; Tekin Nacaroglu H; Yigit O; Zengi O; Salih Akkurt M; Tasdemir M
    Iran Red Crescent Med J; 2016 Nov; 18(11):e41873. PubMed ID: 28203453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity.
    Ugur-Altun B; Altun A; Gerenli M; Tugrul A
    Diabetes Res Clin Pract; 2005 Jun; 68(3):217-22. PubMed ID: 15936463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
    Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating leptin and osteoprotegerin levels affect insulin resistance in healthy premenopausal obese women.
    Ugur-Altun B; Altun A
    Arch Med Res; 2007 Nov; 38(8):891-6. PubMed ID: 17923273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity.
    Ayina Ayina CN; Sobngwi E; Essouma M; Noubiap JJ; Boudou P; Etoundi Ngoa LS; Gautier JF
    Diabetol Metab Syndr; 2015; 7():47. PubMed ID: 26034511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin increases parallel to insulin resistance in obese adolescents.
    Kotanidou EP; Kotanidis CP; Giza S; Serbis A; Tsinopoulou VR; Karalazou P; Tzimagiorgis G; Galli-Tsinopoulou A
    Endocr Res; 2019; 44(1-2):9-15. PubMed ID: 29877745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease.
    Furthner D; Anderwald CH; Bergsten P; Forslund A; Kullberg J; Ahlström H; Manell H; Ciba I; Mangge H; Maruszczak K; Koren P; Schütz S; Brunner SM; Schneider AM; Weghuber D; Mörwald K
    Front Endocrinol (Lausanne); 2022; 13():830012. PubMed ID: 35185803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease.
    Yilmaz Y; Yonal O; Kurt R; Oral AY; Eren F; Ozdogan O; Ari F; Celikel CA; Korkmaz S; Ulukaya E; Imeryuz N; Kalayci C; Avsar E
    Scand J Clin Lab Invest; 2010 Dec; 70(8):541-6. PubMed ID: 20942739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E; González-Reimers E; Santolaria-Fernández F; De la Vega-Prieto MJ; Milena-Abril A; Sánchez-Pérez MJ; Martínez-Riera A; Gómez-Rodríguez Mde L
    Alcohol Alcohol; 2006; 41(3):261-6. PubMed ID: 16476762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1, NON-ALCOHOLIC FATTY LIVER DISEASE, AND ITS RELATIONSHIP WITH FRUCTOSE CONSUMPTION IN CHILDREN WITH OBESITY.
    Flores-Ramírez AG; Ibarra-Reynoso LDR; López-Lemus HL; Olvera-Juárez M; Luevano-Contreras C; Garay-Sevilla ME
    Rev Invest Clin; 2019; 71(5):339-348. PubMed ID: 31599882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D deficiency and insulin resistance as risk factors for dyslipidemia in obese children.
    Erol M; Bostan Gayret Ö; Hamilçıkan Ş; Can E; Yiğit ÖL
    Arch Argent Pediatr; 2017 Apr; 115(2):133-139. PubMed ID: 28318178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
    Sayın O; Tokgöz Y; Arslan N
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease.
    Manco M; Giordano U; Turchetta A; Fruhwirth R; Ancinelli M; Marcellini M; Nobili V
    Acta Diabetol; 2009 Jun; 46(2):97-104. PubMed ID: 18839055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
    Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
    Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of insulin resistance with serum osteoprotegerin in obese adolescents.
    Suliburska J; Bogdanski P; Gajewska E; Kalmus G; Sobieska M; Samborski W
    J Physiol Biochem; 2013 Dec; 69(4):847-53. PubMed ID: 23695991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: A case-control study in China.
    Niu Y; Zhang W; Yang Z; Li X; Fang W; Zhang H; Wang S; Zhou H; Fan J; Qin L; Su Q
    Metabolism; 2016 Apr; 65(4):475-81. PubMed ID: 26975539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation between carotid intima media thickness and serum osteoprotegerin levels in nonalcoholic fatty liver disease.
    Ayaz T; Kirbas A; Durakoglugil T; Durakoglugil ME; Sahin SB; Sahin OZ; Kirvar A; Tasci F
    Metab Syndr Relat Disord; 2014 Jun; 12(5):283-9. PubMed ID: 24689950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.